CYP2D6 poor metabolizers
Warnings and Precautions, Drug Interactions, Use in Specific Populations, Clinical Pharmacology
* Therapeutic areas do not necessarily reflect the CDER review division.
† Standard nomenclature is used for genes as per the Human Genome Organization symbol, cytogenetic abnormalities as per the International System for Human Cytogenetic Nomenclature, or other conventions.
back to Table of Pharmacogenomic Biomarkers in Drug Labeling